22 /100
LOW RISK
Score updated May 28, 2026

CASI — CASI Pharmaceuticals, Inc. Dilution Risk Tracker

Track CASI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CASI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.88 below $1 exchange minimum
🔔 Track CASI — Get forecast alerts →

💹 Market Data

Market Cap$3.21M
Shares Outstanding15.49M
Float9.31M
Cash$17.64M
Debt$38.09M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 42.4% shares (2025Q4 vs prior)
17 institutional holders · 1.51M shares
#1 VR ADVISER, LLC 987.3K shares
#2 BANK OF AMERICA CORP /DE/ 274.8K shares
#3 Woodline Partners LP 133.4K shares
+ 14 more holders Sign up free to view →

📉 Short Interest

Short Interest60.8K
Days to Cover1.0
% of Float0.7%
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CASI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CASI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CASI
📊 CASI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CASI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.